SCM
RNAM

Silverarc Capital Management’s Avidity Biosciences RNAM Stock Holding History

Silverarc Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-844,633
Closed -$36.8M – 95
2025
Q3 		$36.8M Buy
844,633
+434,633
+106% +$17.6M 5.33% 3
2025
Q2 		$11.6M Sell
410,000
-1,312
-0.3% -$39.1K 2.38% 19
2025
Q1 		$12.1M Sell
411,312
-132,339
-24% -$4.12M 2.54% 11
2024
Q4 		$15.8M Buy
543,651
+68,096
+14% +$2.85M 3.54% 10
2024
Q3 		$21.8M Sell
475,555
-42,179
-8% -$1.83M 4.92% 4
2024
Q2 		$21.1M Buy
517,734
+28,431
+6% +$816K 5.22% 3
2024
Q1 		$12.5M Buy
+489,303
New +$7.67M 3.5% 7
2023
Q1 		– Sell
-128,000
Closed -$2.84M – 101
2022
Q4 		$2.84M Buy
+128,000
New +$1.91M 0.98% 42

Other funds holding RNAM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return